tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Technical Analysis

Compare
324 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Immunome is a Buy.
Immunome’s (IMNM) 20-Day exponential moving average is 10.07, while Immunome’s (IMNM) share price is $9.95, making it a Sell.
Immunome’s (IMNM) 50-Day exponential moving average is 9.80, while Immunome’s (IMNM) share price is $9.95, making it a Buy.

Immunome (IMNM) Pivot Points

Aug 28, 2025, 05:22 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.55
9.69
9.93
10.07
10.30
10.44
10.68
Fibonacci
9.69
9.84
9.93
10.07
10.21
10.30
10.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Aug 28, 2025, 05:22 PM
Period
Simple
Exponential
MA5
10.06Sell
10.02Sell
MA10
10.03Sell
10.04Sell
MA20
10.14Sell
10.07Sell
MA50
9.75Buy
9.80Buy
MA100
8.97Buy
9.58Buy
MA200
9.65Buy
10.28Sell
Immunome’s (IMNM) 10-Day exponential moving average is 10.04, while Immunome’s (IMNM) share price is $9.95, making it a Sell.
Immunome’s (IMNM) 100-Day exponential moving average is 9.58, while Immunome’s (IMNM) share price is $9.95, making it a Buy.
Immunome’s (IMNM) stock price is $9.95 and Immunome’s (IMNM) 50-day simple moving average is 9.75, creating a Buy signal.
Immunome’s (IMNM) stock price is $9.95 and Immunome’s (IMNM) 100-day simple moving average is 8.97, creating a Buy signal.
Immunome’s (IMNM) stock price is $9.95 and Immunome’s (IMNM) 200-day simple moving average is 9.65, creating a Buy signal.

Immunome (IMNM) Technical Indicators

Aug 28, 2025, 05:22 PM
Name
Value
Implied Action
RSI (14)
48.75
Neutral
STOCH (9,6)
47.19
Neutral
STOCHRSI (14)
46.13
Neutral
MACD (12,26)
0.01
Buy
ADX (14)
11.15
Buy
Williams %R
-57.24
Buy
CCI (14)
-27.32
Neutral
ATR (14)
0.52
-
Ultimate Oscillator
44.36
Neutral
ROC
0.81
Buy
Immunome’s (IMNM) Relative Strength Index (RSI) is 48.75, creating a Neutral signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 11.15, creating a Buy signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is -27.32, creating a Neutral signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is 0.81, creating a Buy signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Buy.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 48.75, which suggests IMNM is a Neutral.
      What is IMNM’s MACD?
      IMNM’s MACD is 0.01, which suggests IMNM is a Buy.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 10.06, which suggests IMNM is a Sell.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 10.14, which suggests IMNM is a Sell.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 9.75, which suggests IMNM is a Buy.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 9.65, which suggests IMNM is a Buy.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -57.24, which suggests IMNM is a Buy.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is -27.32, which suggests IMNM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis